Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by Gateway Investment Advisers LLC

Gateway Investment Advisers LLC raised its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 9.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,116 shares of the pharmacy operator’s stock after purchasing an additional 1,534 shares during the quarter. Gateway Investment Advisers LLC’s holdings in Walgreens Boots Alliance were worth $162,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Atlas Brown Inc. boosted its holdings in Walgreens Boots Alliance by 1.8% during the first quarter. Atlas Brown Inc. now owns 31,593 shares of the pharmacy operator’s stock worth $685,000 after buying an additional 550 shares in the last quarter. Shilanski & Associates Inc. lifted its position in shares of Walgreens Boots Alliance by 5.3% during the 1st quarter. Shilanski & Associates Inc. now owns 11,821 shares of the pharmacy operator’s stock valued at $256,000 after acquiring an additional 591 shares during the period. First Trust Direct Indexing L.P. boosted its stake in shares of Walgreens Boots Alliance by 1.9% during the 1st quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock worth $696,000 after acquiring an additional 597 shares in the last quarter. Buckley Wealth Management LLC grew its holdings in shares of Walgreens Boots Alliance by 2.1% in the 1st quarter. Buckley Wealth Management LLC now owns 37,335 shares of the pharmacy operator’s stock worth $810,000 after acquiring an additional 785 shares during the period. Finally, FinTrust Capital Advisors LLC increased its stake in Walgreens Boots Alliance by 60.4% in the 1st quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock valued at $46,000 after purchasing an additional 802 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Down 2.3 %

NASDAQ WBA opened at $9.00 on Tuesday. The company’s fifty day moving average price is $9.41 and its two-hundred day moving average price is $13.31. The company has a market capitalization of $7.77 billion, a price-to-earnings ratio of -1.34, a price-to-earnings-growth ratio of 1.04 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a 12 month low of $8.22 and a 12 month high of $27.05. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.65 and a quick ratio of 0.31.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on WBA. JPMorgan Chase & Co. dropped their price target on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. UBS Group cut their target price on shares of Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating for the company in a research report on Wednesday, July 3rd. Barclays reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a report on Tuesday, July 23rd. Truist Financial dropped their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Finally, Evercore ISI lowered their target price on Walgreens Boots Alliance from $17.00 to $10.00 and set an “in-line” rating on the stock in a report on Friday, June 28th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $13.46.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.